The sounds of silence: Public goods, externalities, and the value of infectious disease control programs

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 20, Issue 2, 2009, Pages 39-41

  Fisman, David N ^a,c   Laupland, Kevin B ^b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c PUBLIC HEALTH ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; DISEASE SURVEILLANCE; HEALTH CARE COST; HEALTH PROGRAM; HOSPITAL INFECTION; MARKET; MORBIDITY; NOTE;

EID: 66949118232     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/946012     Document Type: Note

References (13)

1. Attaran A, MacDonald N, Stanbrook MB, et al. Listeriosis is the least of it. CMAJ 2008;179:739-40, 743-744
2. Oliveira M. Raw milk crusader returns to court to fight charges. Globe and Mail, Toronto, 2009. 〈www.theglobeandmail.com/servlet/ story/RTGAM.20090125.wrawmilk0125/BNStory/ specialScienceandHealth/〉 (Version current May 2, 2009).
3. Bauch CT, Earn DJ. Vaccination and the theory of games. Proc Natl Acad Sci U S A 2004;101:13391-13394
4. Abraham C, Priest L. Cost-cutting measures fueled SARS spread. Globe and Mail, Toronto, 2003. 〈www.theglobeandmail.com/servlet/ story/RTGAM. 20030502.wxsars0503/BNStory/Front/〉. (Version current May 2, 2009).
5. MacKinnon JC. The arithmetic of health care. CMAJ 2004;171:603-604 (Pubitemid 39273937)
6. Perencevich EN, Stone PW, Wright SB, Carmeli Y, Fisman DN, Cosgrove SE. Raising standards while watching the bottom line: Making a business case for infection control. Infect Control Hosp Epidemiol 2007;28:1121-1133 (Pubitemid 47580454)
7. Sandler T. Economic Concepts for the Social Sciences, 1st edn. New York: Cambridge University Press, 2001.
8. Anderson R, May R. Infectious Diseases of Humans, 1st edn. Oxford: Oxford University Press, 1992.
9. Pronovost PJ, Goeschel CA, Wachter RM. The wisdom and justice of not paying for "preventable complications". JAMA 2008;299:2197-2199
10. Edmunds WJ, Medley GF, Nokes DJ. Evaluating the cost-effectiveness of vaccination programmes: A dynamic perspective. Stat Med 1999;18:3263-3282
11. Low N. Screening programmes for chlamydial infection: When will we ever learn? BMJ 2007;334:725-728
12. Harris G. Questions Linger Over the Value of a Global Illness Surveillance System. New York Times, New York, 2009. 〈www. nytimes.com/2009/05/02/health/02global.html〉 (Version current May 2, 2009).
13. Naylor D, Basrur S, Bergeron M, et al. SARS in Canada: The anatomy of an outbreak. In: Learning from SARS: Renewal of Public Health in Canada. Ottawa: Publications Health Canada, 2003:23-42.